Surgical Robotics Technology
Auris Health, Inc., a subsidiary of Ethicon, Inc, a Johnson & Johnson MedTech company,* announces four scientific abstract presentations to be delivered at the upcoming annual American Urological Association (AUA) meeting May 13-16, 2022 in New Orleans, LA. This is the first time endourology data will be presented on the MONARCHⓇ Platform, Urology a flexible robotic solution that enables urologists to reach and visualize areas within the kidney with precision and control.
The MONARCH endoscopic robotic platform is now the first and only multispecialty, flexible robotic solution FDA cleared for use in both bronchoscopy and urology. MONARCH® Platform, Urology is a single platform to support both ureteroscopy (URS) and percutaneous nephrolithotomy (PCNL) procedures.
One of the studies to be featured in a podium presentation compared the use of the MONARCH robotic system for urology to the use of conventional devices for URS and PCNL in a porcine model.
“Kidney stones can be incredibly painful and debilitating for patients, and surgery remains the primary care. In working with the Monarch Team on the evolution of urological care in this area, we are striving to make these surgeries more precise and easier to perform, enhancing the available standard of care for our patients,” said Investigator Thomas Chi, MD, Department of Urology, University of California San Francisco.
In another podium presentation, a different study to be presented evaluated radiation exposure of urologists while gaining percutaneous access in a cadaveric model, using either standard-of-care fluoroscopy or an electromagnetic method with the MONARCH robotic system for urology. In addition, Mitchell Humphreys, MD, Department of Urology at Mayo Clinic in Arizona, will also present two posters focusing on urologists’ ability to use MONARCH® Platform, Urology when performing percutaneous access. Most urologists1 in the USA today rely on an interventional radiologist to perform percutaneous access for stone cases.
“We are pleased to share this data of the MONARCH® Platform, Urology with the AUA community, and we appreciate the collaboration with our clinical investigators who helped design and complete these first studies which demonstrate the ability for urologists to use MONARCH for reaching and visualizing areas within the kidney with precision and control,” said Raymond Fryrear, MD Ethicon Global Head Preclinical, Clinical and Medical Affairs for Robotics & Digital Solutions.
For the full list of abstracts, presentation details and more information, visit https://www.eventscribe.net/2022/AUA2022/.
Source: Auris Health.
*Ethicon represents the products and services of Ethicon, Inc., Ethicon Endo-Surgery, LLC, Auris Health, Inc., and certain of their affiliates. All other trademarks are the property of their respective owners.
**Comprising the surgery, orthopedics, vision and interventional solutions businesses within Johnson & Johnson’s MedTech segment.
REFERENCES:
1 Metzler, I. S., Holt, S., & Harper, J.; Surgical Trends in Nephrolithiasis: Increasing De Novo Renal Access by Urologists for Percutaneous Nephrolithotomy. Journal of Endourology. 2021; 35(6): 769-774
